Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings.

The Journal of infectious diseases - 15 Jun 2013

Hosseinipour Mina C, Gupta Ravindra K, Van Zyl Gert, Eron Joseph J, Nachega Jean B

Abstract excerpt

INTRODUCTION: Antiretroviral therapy (ART) in resource-limited settings has expanded in the last decade, reaching >8 million individuals and reducing AIDS mortality and morbidity. Continued success of ART programs will require understanding the emergence of HIV drug resistance patterns among individuals in whom treatment has failed and managing ART from both an individual and public health perspective. We review...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to HIV Infections

Share to HIV Protease Inhibitors

Share to Reverse Transcriptase Inhibitors

Share to Treatment Failure

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 23687289
DOI: 10.1093/infdis/jit107
PMCID: PMC3708738

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings.PMID 23687289Read ↗

HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective.Semantic proximity Read ↗

Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA PanelSemantic proximity Read ↗

Drug Susceptibility and Resistance Mutations After First-Line Failure in Resource Limited SettingsSemantic proximity Read ↗

Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART StrategiesSemantic proximity Read ↗

Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study.Semantic proximity Read ↗

High Prevalence of Drug Resistance Mutations Among Patients Failing First-Line Antiretroviral Therapy and Predictors of Virological Response 24 Weeks After Switch to Second-Line Therapy in São Paulo State, Brazil.Semantic proximity Read ↗

HIV type 1 drug resistance patterns among patients failing first and second line antiretroviral therapy in Nairobi, Kenya.Semantic proximity Read ↗

Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India.Semantic proximity Read ↗

Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.Semantic proximity Read ↗

Current management challenges in HIV: antiretroviral resistance.Semantic proximity Read ↗

HIV type 1 drug resistance in adults receiving highly active antiretroviral therapy in Abidjan, Côte d'Ivoire.Semantic proximity Read ↗

HIV-1 drug resistance and resistance testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.